Literature DB >> 13947981

Cardiac and pulmonary complications in Duchenne's progressive muscular dystrophy.

J GILROY, J L CAHALAN, R BERMAN, M NEWMAN.   

Abstract

Entities:  

Keywords:  ELECTROCARDIOGRAPHY; HEART ENLARGEMENT; MUSCULAR DYSTROPHY; PNEUMONIA; TACHYCARDIA

Mesh：

Year:  1963        PMID： 13947981     DOI： 10.1161/01.cir.27.4.484

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  23 in total

1.  Cooperative International Neuromuscular Research Group Duchenne Natural History Study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy.

Authors:  Christopher Spurney; Reiko Shimizu; Lauren P Morgenroth; Hanna Kolski; Heather Gordish-Dressman; Paula R Clemens
Journal:  Muscle Nerve       Date:  2014-05-14       Impact factor: 3.217

2.  Acute pericardial tamponade complicating spinal surgery in a child with Duchenne muscular dystrophy.

Authors:  N A Watkin; I Ostman-Smith; L Padgett; J C Fairbank
Journal:  Eur Spine J       Date:  1993-10       Impact factor: 3.134

3.  Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy.

Authors:  Tamara O Thomas; Thomas M Morgan; William B Burnette; Larry W Markham
Journal:  Pediatr Cardiol       Date:  2012-03-21       Impact factor: 1.655

4.  Clinical demonstrations.

Authors:  J F Goodwin
Journal:  Postgrad Med J       Date:  1972-12       Impact factor: 2.401

5.  Classification of the secondary cardiomyopathies. The pathologist's view.

Authors:  A Pomerance
Journal:  Postgrad Med J       Date:  1972-12       Impact factor: 2.401

6.  Abnormalities of the electrocardiogram in hereditary myopathies.

Authors:  A E Emery
Journal:  J Med Genet       Date:  1972-03       Impact factor: 6.318

7.  Cardiorespiratory changes in progressive muscular dystrophy.

Authors:  P L Wahi; K C Bhargava; S Mohindra
Journal:  Br Heart J       Date:  1971-07

8.  Echocardiographic assessment of left ventricular function in Duchenne's muscular dystrophy.

Authors:  M Ahmad; J E Sanderson; V Dubowitz; K A Hallidie-Smith
Journal:  Br Heart J       Date:  1978-07

9.  Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.

Authors:  Kitipong Uaesoontrachoon; James L Quinn; Kathleen S Tatem; Jack H Van Der Meulen; Qing Yu; Aditi Phadke; Brittany K Miller; Heather Gordish-Dressman; Ennio Ongini; Daniela Miglietta; Kanneboyina Nagaraju
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

10.  Cardiomyopathy of Duchenne muscular dystrophy.

Authors:  L D'Orsogna; J P O'Shea; G Miller
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.